Article Information
History
- August 6, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Frauke Muecksch, post-doctoral scientist1,
- Helen Wise, Clinical Scientist2,*,
- Becky Batchelor, Senior Clinical Scientist2,*,
- Maria Squires, Senior Clinical Scientist2,*,
- Elizabeth Semple, Biomedical Scientist2,
- Claire Richardson, Biomedical Scientist3,
- Jacqueline McGuire, consultant clinical scientist3,
- Sarah Clearly, consultant clinical scientist3,
- Elizabeth Furrie, Consultant Immunologist4,
- Neil Greig, Consultant Biochemist4,
- Gordon Hay, Biomedical Scientist4,
- Kate Templeton, Consultant Virologist2,
- Julio C.C. Lorenzi, research associate5,
- Theodora Hatziioannou, associate professor1,
- Sara Jenks, Consultant Biochemist2 and
- Paul D. Bieniasz, professor2,3,†
- 1Laboratory of Retrovirology, The Rockefeller University, 1230 York Avenue, New York NY 10065
- 2Royal Infirmary of Edinburgh, NHS Lothian, 51 Little France Crescent, Edinburgh EH16 4SA
- 3University Hospital Monklands, NHS Lanarkshire, Airdrie ML6 0JS
- 4Ninewells Hospital and Medical School, NHS Tayside, Dundee DD1 9SY
- 5Laboratory of Molecular Immunology, The Rockefeller University, 1230 York Avenue, New York NY 10065
- 6Howard Hughes Medical Institute, The Rockefeller University, 1230 York Avenue, New York NY 10065
- ↵†Correspondence to: Paul D. Bieniasz, Laboratory of Retrovirology, The Rockefeller University, 1230 York Avenue, New York NY 10065 E.Mail pbieniasz{at}rockefeller.edu
↵* Equal contribution
Posted August 06, 2020.
Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents
